BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29331574)

  • 21. A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer.
    Lim KH; Lu JJ; Wynne CJ; Back MF; Mukherjee R; Razvi K; Shakespeare TP
    Am J Clin Oncol; 2004 Oct; 27(5):449-51. PubMed ID: 15596908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancer.
    Wilson JM; Davies E; Tan X; Brewster W; Jones E; Weiner AA
    Brachytherapy; 2021; 20(6):1164-1171. PubMed ID: 34620572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment planning for high dose rate brachytherapy of cervical cancer based on total dose constraints.
    Bahadur YA; Constantinescu CT; Hassouna AH; El-Sayed ME
    Saudi Med J; 2011 May; 32(5):495-503. PubMed ID: 21556471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary results of a new workflow for MRI/CT-based image-guided brachytherapy in cervical carcinoma.
    Nemoto MW; Iwai Y; Togasaki G; Kurokawa M; Harada R; Kobayashi H; Uno T
    Jpn J Radiol; 2017 Dec; 35(12):760-765. PubMed ID: 29039108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomic structure-based deformable image registration of brachytherapy implants in the treatment of locally advanced cervix cancer.
    Ryckman JM; Shelton JW; Waller AF; Schreibmann E; Latifi K; Diaz R
    Brachytherapy; 2016; 15(5):584-92. PubMed ID: 27263057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound.
    Van Dyk S; Narayan K; Fisher R; Bernshaw D
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):64-70. PubMed ID: 19250767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms.
    Kim RY; Pareek P
    Brachytherapy; 2003; 2(4):200-6. PubMed ID: 15062127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept.
    Nesvacil N; Schmid MP; Pötter R; Kronreif G; Kirisits C
    Brachytherapy; 2016; 15(6):839-844. PubMed ID: 27693172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Swanick CW; Castle KO; Vedam S; Munsell MF; Turner LM; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):793-800. PubMed ID: 27788952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
    Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
    Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: standardized template planning vs. computerized treatment planning.
    Patone H; Souhami L; Parker W; Evans M; Duclos M; Portelance L
    Brachytherapy; 2008; 7(3):254-9. PubMed ID: 18579447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laminaria tent insertion in preplanning MRI for CT-based cervical cancer brachytherapy.
    Takagawa Y; Izumi S; Kita M
    Brachytherapy; 2022; 21(2):170-176. PubMed ID: 34933809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of uterus position as a surrogate for high-risk clinical target volume with respect to the applicator position for multiple fractions of brachytherapy in cervical cancer.
    Cooper R; Brearley E; Hurmuz P; Musunuru HB; Richardson C; Swift S; Orton J; Bownes P
    Arch Gynecol Obstet; 2014 Dec; 290(6):1201-5. PubMed ID: 25001571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.
    Thiruthaneeswaran N; Groom N; Lowe G; Bryant L; Hoskin PJ
    Brachytherapy; 2018; 17(1):181-186. PubMed ID: 29153466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing the impact of adaptive planning on image-guided perineal interstitial brachytherapy for gynecologic malignancies.
    Gladwish A; Ravi A; Barbera L; Mendez L; Davidson M; D'Alimonte L; D'Souza D; Wronski M; Leung E
    Brachytherapy; 2018; 17(2):352-359. PubMed ID: 29241705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.